<DOC>
	<DOCNO>NCT01051778</DOCNO>
	<brief_summary>The aim study compare efficacy safety Low molecular weight heparin ( LMWH ) plus low dose aspirin ( LDA ) unfractionated heparin ( UFH ) plus LDA woman recurrent pregnancy loss associate antiphospholipid syndrome ( APS ) .</brief_summary>
	<brief_title>Low-molecular-weight Heparin ( LMWH ) Versus Unfractionated Heparin ( UFH ) Pregnant Women With Recurrent Abortion Secondary Antiphospholipid Syndrome</brief_title>
	<detailed_description>Women antiphospholipid syndrome ( APS ) live birth rate low 10 % pregnancy without pharmacological treatment . Low dose aspirin ( LDA ) , unfractionated heparin ( UFH ) , Low molecular weight heparin ( LMWH ) , prednisone , intravenous immunoglobulin ( IVIG ) use either alone combination order improve live birth rate APS positive woman recurrent miscarriage . A Cochrane review 13 randomized quasi-randomized , control trial various management option pregnant woman history pregnancy loss APL , reveal combined UFH aspirin treatment choice reduce pregnancy loss 54 % . During past decade , low molecular weight heparin widely use prophylaxis treatment patient venous arterial thrombosis , efficacy safety superior least equivalent UFH .Although recent study report use LMWH management patient recurrent pregnancy loss secondary antiphospholipid syndrome result encouraging result . It clear whether efficacy safety LMWH equivalent UFH . Although LMWH expensive UFH . LMWH long half life , great bioavailability , stable dose-response relationship UFH therefore administer daily . Furthermore , LMWH require less frequent monitoring UFH le adverse effect bone mineral density platelet count .These advantage make LMWH attractive patient physician UFH . There two study compare efficacy LMWH plus LDA UFH plus LDA management pregnant woman recurrent pregnancy loss secondary APS . In addition , randomize control study yet compare efficacy LMWH plus LDA UFH plus LDA . The aim study compare efficacy safety Low molecular weight heparin ( LMWH ) plus low dose aspirin ( LDA ) unfractionated heparin ( UFH ) plus LDA woman recurrent pregnancy loss associate antiphospholipid syndrome ( APS ) .</detailed_description>
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Patients minimum three consecutive pregnancy loss 10 week gestation Positive lupus anticoagulant and/or anticardiolipin antibody ( IgG IgM ) least two occasion twelve week apart . Age 19 37 year , Body mass index 1930 Parental chromosomal abnormality Uterine abnormality Luteal phase defect Systemic lupus erythematosus Previous thromboembolism Sensitivity aspirin .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Recurrent abortion</keyword>
	<keyword>Antiphospholipid syndrome</keyword>
	<keyword>unfractionated heparin</keyword>
	<keyword>Low Molecular Weight Heparin</keyword>
</DOC>